Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers found in a clinical trial. File Photo by Brian Kersey/UPI A powerful new ...

Huge improvements in prevention, diagnosis and treatment have driven the fall, Cancer Research UK says ...

Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...

Cancer death rates in the UK have hit a record low, but the picture is more complicated than the headline figure suggests.

Iowa’s cancer rate is the second worst in the nation for three years running, and a comprehensive study being released today offers little optimism.

In prostate cancer, prostate brachytherapy boost improves biochemical failure at 10 years but does not prolong long-term OS compared to EBRT boost.

Cancer death rates in the UK have fallen to a historic new low, Cancer Research UK has announced. The charity, which analysed ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.